12-2557182-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000719.7(CACNA1C):​c.1508+205A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.658 in 152,074 control chromosomes in the GnomAD database, including 34,166 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.66 ( 34166 hom., cov: 33)

Consequence

CACNA1C
NM_000719.7 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.102

Publications

6 publications found
Variant links:
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
CACNA1C Gene-Disease associations (from GenCC):
  • Timothy syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics
  • long QT syndrome
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • long QT syndrome 8
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • Brugada syndrome
    Inheritance: AD Classification: SUPPORTIVE, NO_KNOWN Submitted by: Orphanet, ClinGen
  • Brugada syndrome 3
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • intellectual disability
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • short QT syndrome
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 12-2557182-A-G is Benign according to our data. Variant chr12-2557182-A-G is described in ClinVar as Benign. ClinVar VariationId is 671798.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.733 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1CNM_000719.7 linkc.1508+205A>G intron_variant Intron 11 of 46 ENST00000399655.6 NP_000710.5 Q13936-12
CACNA1CNM_001167623.2 linkc.1508+205A>G intron_variant Intron 11 of 46 ENST00000399603.6 NP_001161095.1 Q13936-37

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1CENST00000399603.6 linkc.1508+205A>G intron_variant Intron 11 of 46 5 NM_001167623.2 ENSP00000382512.1 Q13936-37
CACNA1CENST00000399655.6 linkc.1508+205A>G intron_variant Intron 11 of 46 1 NM_000719.7 ENSP00000382563.1 Q13936-12
CACNA1CENST00000682544.1 linkc.1598+205A>G intron_variant Intron 11 of 49 ENSP00000507184.1 A0A804HIR0
CACNA1CENST00000406454.8 linkc.1508+205A>G intron_variant Intron 11 of 47 5 ENSP00000385896.3 F5GY28
CACNA1CENST00000399634.6 linkc.1508+205A>G intron_variant Intron 11 of 46 5 ENSP00000382542.2 E9PDI6
CACNA1CENST00000683824.1 linkc.1673+205A>G intron_variant Intron 12 of 47 ENSP00000507867.1 A0A804HKC4
CACNA1CENST00000347598.9 linkc.1508+205A>G intron_variant Intron 11 of 48 1 ENSP00000266376.6 Q13936-11
CACNA1CENST00000344100.7 linkc.1508+205A>G intron_variant Intron 11 of 46 1 ENSP00000341092.3 Q13936-14
CACNA1CENST00000327702.12 linkc.1508+205A>G intron_variant Intron 11 of 47 1 ENSP00000329877.7 A0A0A0MR67
CACNA1CENST00000399617.6 linkc.1508+205A>G intron_variant Intron 11 of 47 5 ENSP00000382526.1 A0A0A0MSA1
CACNA1CENST00000682462.1 linkc.1598+205A>G intron_variant Intron 11 of 46 ENSP00000507105.1 A0A804HIJ8
CACNA1CENST00000683781.1 linkc.1598+205A>G intron_variant Intron 11 of 46 ENSP00000507434.1 A0A804HJB6
CACNA1CENST00000683840.1 linkc.1598+205A>G intron_variant Intron 11 of 46 ENSP00000507612.1 A0A804HJR1
CACNA1CENST00000683956.1 linkc.1598+205A>G intron_variant Intron 11 of 46 ENSP00000506882.1 A0A804HI37
CACNA1CENST00000399638.5 linkc.1508+205A>G intron_variant Intron 11 of 47 1 ENSP00000382547.1 Q13936-31
CACNA1CENST00000335762.10 linkc.1583+205A>G intron_variant Intron 12 of 47 5 ENSP00000336982.5 F5H522
CACNA1CENST00000399606.5 linkc.1508+205A>G intron_variant Intron 11 of 47 1 ENSP00000382515.1 Q13936-30
CACNA1CENST00000399621.5 linkc.1508+205A>G intron_variant Intron 11 of 46 1 ENSP00000382530.1 Q13936-24
CACNA1CENST00000399637.5 linkc.1508+205A>G intron_variant Intron 11 of 46 1 ENSP00000382546.1 Q13936-27
CACNA1CENST00000402845.7 linkc.1508+205A>G intron_variant Intron 11 of 46 1 ENSP00000385724.3 Q13936-13
CACNA1CENST00000399629.5 linkc.1508+205A>G intron_variant Intron 11 of 46 1 ENSP00000382537.1 Q13936-32
CACNA1CENST00000682336.1 linkc.1583+205A>G intron_variant Intron 12 of 46 ENSP00000507898.1 A0A804HKE9
CACNA1CENST00000399591.5 linkc.1508+205A>G intron_variant Intron 11 of 45 1 ENSP00000382500.1 Q13936-29
CACNA1CENST00000399595.5 linkc.1508+205A>G intron_variant Intron 11 of 45 1 ENSP00000382504.1 Q13936-25
CACNA1CENST00000399649.5 linkc.1508+205A>G intron_variant Intron 11 of 45 1 ENSP00000382557.1 Q13936-15
CACNA1CENST00000399597.5 linkc.1508+205A>G intron_variant Intron 11 of 46 1 ENSP00000382506.1 Q13936-22
CACNA1CENST00000399601.5 linkc.1508+205A>G intron_variant Intron 11 of 46 1 ENSP00000382510.1 Q13936-20
CACNA1CENST00000399641.6 linkc.1508+205A>G intron_variant Intron 11 of 46 1 ENSP00000382549.1 Q13936-23
CACNA1CENST00000399644.5 linkc.1508+205A>G intron_variant Intron 11 of 46 1 ENSP00000382552.1 Q13936-21
CACNA1CENST00000682835.1 linkc.1508+205A>G intron_variant Intron 11 of 46 ENSP00000507282.1 A0A804HIZ0
CACNA1CENST00000683482.1 linkc.1499+205A>G intron_variant Intron 11 of 46 ENSP00000507169.1 Q13936-35
CACNA1CENST00000682686.1 linkc.1508+205A>G intron_variant Intron 11 of 45 ENSP00000507309.1 Q13936-19
CACNA1CENST00000480911.6 linkn.*115+205A>G intron_variant Intron 9 of 26 5 ENSP00000437936.2 F5H638

Frequencies

GnomAD3 genomes
AF:
0.659
AC:
100081
AN:
151956
Hom.:
34163
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.474
Gnomad AMI
AF:
0.784
Gnomad AMR
AF:
0.668
Gnomad ASJ
AF:
0.656
Gnomad EAS
AF:
0.737
Gnomad SAS
AF:
0.727
Gnomad FIN
AF:
0.778
Gnomad MID
AF:
0.680
Gnomad NFE
AF:
0.738
Gnomad OTH
AF:
0.644
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.658
AC:
100106
AN:
152074
Hom.:
34166
Cov.:
33
AF XY:
0.662
AC XY:
49216
AN XY:
74364
show subpopulations
African (AFR)
AF:
0.474
AC:
19640
AN:
41472
American (AMR)
AF:
0.668
AC:
10203
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.656
AC:
2276
AN:
3470
East Asian (EAS)
AF:
0.737
AC:
3810
AN:
5168
South Asian (SAS)
AF:
0.726
AC:
3493
AN:
4814
European-Finnish (FIN)
AF:
0.778
AC:
8242
AN:
10598
Middle Eastern (MID)
AF:
0.684
AC:
201
AN:
294
European-Non Finnish (NFE)
AF:
0.738
AC:
50180
AN:
67952
Other (OTH)
AF:
0.637
AC:
1348
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1669
3339
5008
6678
8347
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
804
1608
2412
3216
4020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.684
Hom.:
54708
Bravo
AF:
0.645
Asia WGS
AF:
0.653
AC:
2269
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:1
Jun 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Long QT syndrome Benign:1
Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
1.1
DANN
Benign
0.67
PhyloP100
-0.10
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2370596; hg19: chr12-2666348; API